Baldwin Brothers LLC Merck & Co., Inc. Transaction History

Baldwin Brothers LLC

$1.43 Billion
Q3 2024

A detailed history of Baldwin Brothers LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Baldwin Brothers LLC holds 189,120 shares of MRK stock, worth $18.2 Million. This represents 1.5% of its overall portfolio holdings.

Number of Shares

189,120

Previous 182,931 3.38%

Holding current value

$18.2 Million

Previous $22.6 Million 5.17%

% of portfolio

1.5%

Previous 1.78%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$111.15 - $128.97 $687,907 - $798,195	6,189 Added 3.38%	189,120 $21.5 Million
Q2 2024 Jul 12, 2024	SELL	$123.8 - $132.96 $955,612 - $1.03 Million	-7,719 Reduced 4.05%	182,931 $22.6 Million
Q1 2024 Apr 12, 2024	SELL	$113.24 - $131.95 $217,534 - $253,475	-1,921 Reduced 1.0%	190,650 $25.2 Million
Q4 2023 Jan 08, 2024	BUY	$100.18 - $109.02 $631,835 - $687,589	6,307 Added 3.39%	192,571 $21 Million
Q3 2023 Oct 10, 2023	SELL	$102.95 - $114.33 $397,695 - $441,656	-3,863 Reduced 2.03%	186,264 $19.2 Million
Q2 2023 Jul 14, 2023	SELL	$108.61 - $118.38 $5,213 - $5,682	-48 Reduced 0.03%	190,127 $21.9 Million
Q1 2023 Apr 21, 2023	SELL	$102.94 - $114.86 $273,305 - $304,953	-2,655 Reduced 1.38%	190,175 $20.2 Million
Q4 2022 Jan 27, 2023	BUY	$87.44 - $112.11 $1.46 Million - $1.88 Million	16,726 Added 9.5%	192,830 $0
Q3 2022 Oct 14, 2022	SELL	$84.53 - $94.96 $236,261 - $265,413	-2,795 Reduced 1.56%	176,104 $15.2 Million
Q2 2022 Jul 18, 2022	SELL	$83.49 - $94.64 $747,569 - $847,406	-8,954 Reduced 4.77%	178,899 $16.3 Million
Q1 2022 Apr 13, 2022	BUY	$73.51 - $82.4 $206,857 - $231,873	2,814 Added 1.52%	187,853 $15.4 Million
Q4 2021 Jan 14, 2022	BUY	$72.28 - $90.54 $72,207 - $90,449	999 Added 0.54%	185,039 $14.2 Million
Q3 2021 Oct 27, 2021	BUY	$71.68 - $78.83 $50,749 - $55,811	708 Added 0.39%	184,040 $13.8 Million
Q2 2021 Jul 30, 2021	SELL	$70.31 - $77.77 $3,374 - $3,732	-48 Reduced 0.03%	183,332 $14.3 Million
Q1 2021 Apr 08, 2021	BUY	$68.86 - $81.11 $316,067 - $372,294	4,590 Added 2.57%	183,380 $14.1 Million
Q4 2020 Jan 12, 2021	SELL	$71.77 - $79.65 $85,908 - $95,341	-1,197 Reduced 0.67%	178,790 $14.6 Million
Q3 2020 Oct 16, 2020	SELL	$73.18 - $82.95 $225,028 - $255,071	-3,075 Reduced 1.68%	179,987 $14.9 Million
Q2 2020 Jul 21, 2020	SELL	$70.42 - $80.13 $75,983 - $86,460	-1,079 Reduced 0.59%	183,062 $14.2 Million
Q1 2020 Apr 15, 2020	BUY	$63.36 - $87.82 $207,313 - $287,347	3,272 Added 1.81%	184,141 $14.2 Million
Q4 2019 Jan 29, 2020	SELL	$77.58 - $87.54 $13,421 - $15,144	-173 Reduced 0.1%	180,869 $16.5 Million
Q3 2019 Oct 10, 2019	SELL	$76.08 - $82.93 $10,118 - $11,029	-133 Reduced 0.07%	181,042 $15.2 Million
Q2 2019 Jul 19, 2019	SELL	$69.84 - $81.59 $206,028 - $240,690	-2,950 Reduced 1.6%	181,175 $15.2 Million
Q1 2019 Apr 24, 2019	SELL	$69.58 - $79.36 $1.1 Million - $1.25 Million	-15,746 Reduced 7.88%	184,125 $15.3 Million
Q4 2018 Feb 01, 2019	SELL	$65.24 - $75.71 $90,096 - $104,555	-1,381 Reduced 0.69%	199,871 $15.3 Million
Q3 2018 Oct 26, 2018	SELL	$57.69 - $67.84 $1.7 Million - $2 Million	-29,540 Reduced 12.8%	201,252 $14.3 Million
Q2 2018 Jul 24, 2018	SELL	$50.83 - $59.72 $46,356 - $54,464	-912 Reduced 0.39%	230,792 $14 Million
Q1 2018 Apr 16, 2018	BUY	$50.96 - $59.23 $597,098 - $693,997	11,717 Added 5.33%	231,704 $12.6 Million
Q4 2017 Jan 24, 2018	SELL	$51.62 - $61.64 $306,003 - $365,401	-5,928 Reduced 2.62%	219,987 $12.4 Million
Q3 2017 Oct 26, 2017	BUY	$58.67 - $63.13 $13.3 Million - $14.3 Million	225,915	225,915 $14.5 Million

Others Institutions Holding MRK

# of Institutions

3,821

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $244B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.

Account

Baldwin Brothers LLC Merck & Co., Inc. Transaction History